Oncology, Domestic Firms Dominate New China Approvals As Innovation Gathers Pace

 
• By Dexter Jie Yan
  
Approvals
Anticancer drugs continue to take up lion’s share of new China approvals • Source: Alamy

More from China

More from Asia